Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 0.80 · gapped below the open, never looked back. High/low 0.80 at 3:30 pm ET, 0.79 at 10:00 am ET.
Hyperfine, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Electromedical & Electrotherapeutic Apparatus
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“We rely on a single contract manufacturer, Benchmark, to test, assemble and supply our finished products.”
FILING10-K0001193125-26-114044cik 0001833769
“On March 18, 2026 (the "Loan Closing Date"), we entered into a Loan and Security Agreement (the "Loan Agreement") with Horizon Technology Finance Management LLC (the "Lender"), providing for a senior secured term loan facility of up to $40.0 million, with $15.0 million funded on the Loan Closing Date.”
FILING10-K0001193125-26-114044cik 0001833769
“On October 17, 2025, we closed an underwritten public offering (the " October 2025 Offering " ), in which we issued and sold 14,000,000 shares of our Class A common stock at a public offering price of $1.25 per share, pursuant to an Underwriting Agreement (the " Underwriting Agreement " ) with Lake Street Capital Markets, LLC, as the underwriter.”
FILING10-K0001193125-26-114044cik 0001833769
“The Shelf Registration Statement also included a prospectus supplement covering up to an aggregate of $50.0 million in shares of Class A common stock that we could issue and sell from time to time through B. Riley Securities, Inc. ("B. Riley"), acting as our sales agent, pursuant to a sales agreement for our "at-the-market" equity program that we entered into with B. Riley in November 2023 (the "Sales Agreement").”
FILING10-K0001193125-26-114044cik 0001833769
“During 2020 and 2021, we were awarded multiple grants totaling $4.9 million from the BMGF for the provision and equipping of sites with our portable MR brain imaging system to enable the performance of a multi-site study focused on optimizing diagnostic image quality.”
FILING10-K0001193125-26-114044cik 0001833769
“On December 29, 2025, we filed a new prospectus supplement covering up to an aggregate of $50.0 million in shares of Class A common stock that we may issue and sell from time to time, through B. Riley and BTIG, LLC ("BTIG") acting as our sales agents, pursuant to the amended and restated sales agreement that we entered into with B. Riley and BTIG on December 29, 2025 (the "Amended Sales Agreement"), for our "at-the-market" equity program.”
FILING10-K0001193125-26-114044cik 0001833769
“A TSEA by and among Butterfly Network, Inc., OrphAI Therapeutics Inc. (f/k/a AI Therapeutics, Inc.), Quantum-Si Incorporated, 4Bionics LLC, identifeye Health Inc. (f/k/a Tesseract Health, Inc.), Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics LLC, identifeye Health Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, OrphAI Therapeutics Inc., identifeye Health Inc. and Detect, Inc. was signed in July 2021 and became effective upon the closing of our December 2021 business combination.”
FILING10-K0001193125-26-114044cik 0001833769
“A TSEA by and among Butterfly Network, Inc., OrphAI Therapeutics Inc. (f/k/a AI Therapeutics, Inc.), Quantum-Si Incorporated, 4Bionics LLC, identifeye Health Inc. (f/k/a Tesseract Health, Inc.), Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics LLC, identifeye Health Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, OrphAI Therapeutics Inc., identifeye Health Inc. and Detect, Inc. was signed in July 2021 and became effective upon the closing of our December 2021 business combination.”
FILING10-K0001193125-26-114044cik 0001833769
“A TSEA by and among Butterfly Network, Inc., OrphAI Therapeutics Inc. (f/k/a AI Therapeutics, Inc.), Quantum-Si Incorporated, 4Bionics LLC, identifeye Health Inc. (f/k/a Tesseract Health, Inc.), Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics LLC, identifeye Health Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, OrphAI Therapeutics Inc., identifeye Health Inc. and Detect, Inc. was signed in July 2021 and became effective upon the closing of our December 2021 business combination.”
FILING10-K0001193125-26-114044cik 0001833769
“A TSEA by and among Butterfly Network, Inc., OrphAI Therapeutics Inc. (f/k/a AI Therapeutics, Inc.), Quantum-Si Incorporated, 4Bionics LLC, identifeye Health Inc. (f/k/a Tesseract Health, Inc.), Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics LLC, identifeye Health Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, OrphAI Therapeutics Inc., identifeye Health Inc. and Detect, Inc. was signed in July 2021 and became effective upon the closing of our December 2021 business combination.”
FILING10-K0001193125-26-114044cik 0001833769
“A TSEA by and among Butterfly Network, Inc., OrphAI Therapeutics Inc. (f/k/a AI Therapeutics, Inc.), Quantum-Si Incorporated, 4Bionics LLC, identifeye Health Inc. (f/k/a Tesseract Health, Inc.), Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics LLC, identifeye Health Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, OrphAI Therapeutics Inc., identifeye Health Inc. and Detect, Inc. was signed in July 2021 and became effective upon the closing of our December 2021 business combination.”
FILING10-K0001193125-26-114044cik 0001833769
Watchlist prices, news filtered to it, and its next report on your desk.
Hyperfine, Inc. has 11 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Hyperfine, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Hyperfine, Inc.. Customers appear here when Hyperfine, Inc. names them, or when a company names Hyperfine, Inc. as a supplier in its own annual report.
HYPR (Hyperfine, Inc.) has 11 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BHE −0.08%, in semiconductor.